ammonium lactate
Trade name: lac-hydrin
Small moleculewithdrawn
Approved
Apr 24, 1985
Ammonium lactate is a compound with formula NH4(C2H4(OH)COO). It is the ammonium salt of lactic acid. It has mild anti-bacterial properties. — Wikipedia
Clinical trial activity
5 trials · 3 clinical orgs · 5 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
4
Phase 4
1
Earliest trial started Jan 1, 2009 (NCT01111123)
Timeline
1980s
- Apr 24, 1985
Sun Pharmaceuticals — Earliest FDA Approval
- Apr 24, 1985
Sun Pharmaceuticals — NDA Organization
- Apr 24, 1985
Sun Pharmaceuticals — NDA Secondary Org
2000s
- May 1, 2002
Padagis Us — Marketing Organization
- May 1, 2002
Perrigo — Marketing Organization
- Jun 11, 2002
Watson Pharmaceuticals — Marketing Organization
- Apr 10, 2003
Taro Pharmaceuticals — Marketing Organization
2010s
- Jan 1, 2017
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Unknown
Approval history
- withdrawnApr 24, 1985
Chemistry & pharmacology
Loading structure…
SMILES
CC(O)C(=O)O.N- Mol. weight
- 107.11 g/mol
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaAmmonium lactate ↗
- ChEMBLCHEMBL1200747 ↗
Also known as
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium lactate
- ammonium (+-)-lactate
- ammonium (+-)-lactate
- bms-186091
- bms-186091
- e328
- e328
- lac-hydrin
- lac-hydrin
- lac-hydrin
- lactic acid ammonium salt
- lactic acid ammonium salt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06444763 | Phase 3 | Nov 15, 2024 | RDC Clinical Pty Ltd |
| NCT06436781 | Phase 3 | Sep 12, 2024 | RDC Clinical Pty Ltd |
| NCT06104917 | Phase 3 | Nov 30, 2023 | RDC Clinical Pty Ltd |
| NCT04127513 | Phase 3 | Apr 1, 2017 | University of Indonesia |
| NCT01111123 | Phase 4 | Jan 1, 2009 | Icahn School of Medicine at Mount Sinai |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RDC Clinical Pty Ltd | For profit | 3 | 3 | 1 | 2023 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of Indonesia | Academic/Hospital | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1
Marketing (7)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Padagis Us | For profit | MKTG | May 1, 2002 |
| Perrigo | For profit | MKTG | May 1, 2002 |
| Perrigo | For profit | SYN | May 1, 2002 |
| Sun Pharmaceuticals | For profit | NDA | Apr 24, 1985 |
| Sun Pharmaceuticals | For profit | NDA2 | Apr 24, 1985 |
| Taro Pharmaceuticals | For profit | MKTG | Apr 10, 2003 |
| Watson Pharmaceuticals | For profit | MKTG | Jun 11, 2002 |